Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Biology and Translational Studies

Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Lluís Nisa, Paola Francica, Roland Giger, Matúš Medo, Olgun Elicin, Manja Friese-Hamim, Claudia Wilm, Christopher Stroh, Beat Bojaxhiu, Aurélie Quintin, Marco D. Caversaccio, Matthias S. Dettmer, Mélanie Buchwalder, Tess M. Brodie, Daniel M. Aebersold, Yitzhak Zimmer, Thomas E. Carey and Michaela Medová
Lluís Nisa
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Francica
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Giger
3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matúš Medo
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olgun Elicin
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olgun Elicin
Manja Friese-Hamim
4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Wilm
4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Stroh
4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beat Bojaxhiu
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélie Quintin
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco D. Caversaccio
3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias S. Dettmer
5Institute of Pathology, University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthias S. Dettmer
Mélanie Buchwalder
3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
5Institute of Pathology, University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tess M. Brodie
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
6Mass Cytometry Facility, University of Zurich, Zurich, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel M. Aebersold
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel M. Aebersold
Yitzhak Zimmer
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas E. Carey
7Department of Otolaryngology – Head and Neck Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan.
8Comprehensive Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas E. Carey
Michaela Medová
1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michaela Medová
  • For correspondence: michaela.medova@dbmr.unibe.ch
DOI: 10.1158/1535-7163.MCT-18-1274 Published February 2020
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2019 to January 2021

AbstractFull-text HTMLPDF
Total1607121314

Cited By

Article Information

Volume 19, Issue 2, pp. 614-626

DOI 
https://doi.org/10.1158/1535-7163.MCT-18-1274
PubMed 
31744898

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received November 13, 2018
  • Revision received August 19, 2019
  • Accepted November 14, 2019
  • Published first November 19, 2019.

Article Versions

  • Previous version (November 19, 2019 - 07:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2019 American Association for Cancer Research.

Author Information

  1. Lluís Nisa1,2,3,
  2. Paola Francica1,2,
  3. Roland Giger3,
  4. Matúš Medo1,2,
  5. Olgun Elicin2,
  6. Manja Friese-Hamim4,
  7. Claudia Wilm4,
  8. Christopher Stroh4,
  9. Beat Bojaxhiu2,
  10. Aurélie Quintin1,2,
  11. Marco D. Caversaccio3,
  12. Matthias S. Dettmer5,
  13. Mélanie Buchwalder3,5,
  14. Tess M. Brodie1,2,6,
  15. Daniel M. Aebersold1,2,
  16. Yitzhak Zimmer1,2,
  17. Thomas E. Carey7,8, and
  18. Michaela Medová1,2,*
  1. 1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  2. 2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  3. 3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  4. 4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.
  5. 5Institute of Pathology, University of Bern, Bern, Switzerland.
  6. 6Mass Cytometry Facility, University of Zurich, Zurich, Switzerland.
  7. 7Department of Otolaryngology – Head and Neck Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan.
  8. 8Comprehensive Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan.
  1. ↵*Corresponding Author:
    Michaela Medová, Inselspital, Bern University Hospital, and University of Bern, Murtenstrasse 35, 3008 Bern, Switzerland. Phone: 41-3163-23565; Fax: 41-3163-23297; E-mail: michaela.medova{at}dbmr.unibe.ch
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 19 (2)
February 2020
Volume 19, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Lluís Nisa, Paola Francica, Roland Giger, Matúš Medo, Olgun Elicin, Manja Friese-Hamim, Claudia Wilm, Christopher Stroh, Beat Bojaxhiu, Aurélie Quintin, Marco D. Caversaccio, Matthias S. Dettmer, Mélanie Buchwalder, Tess M. Brodie, Daniel M. Aebersold, Yitzhak Zimmer, Thomas E. Carey and Michaela Medová
Mol Cancer Ther February 1 2020 (19) (2) 614-626; DOI: 10.1158/1535-7163.MCT-18-1274

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Lluís Nisa, Paola Francica, Roland Giger, Matúš Medo, Olgun Elicin, Manja Friese-Hamim, Claudia Wilm, Christopher Stroh, Beat Bojaxhiu, Aurélie Quintin, Marco D. Caversaccio, Matthias S. Dettmer, Mélanie Buchwalder, Tess M. Brodie, Daniel M. Aebersold, Yitzhak Zimmer, Thomas E. Carey and Michaela Medová
Mol Cancer Ther February 1 2020 (19) (2) 614-626; DOI: 10.1158/1535-7163.MCT-18-1274
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Galunisertib and SBRT in Patients with Advanced HCC
  • CF33 Viroimmunotherapy Cross-Primes T Cells in Colon Cancer
  • Hsp90 Inhibition and PD-1 Blockade
Show more Cancer Biology and Translational Studies
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement